Prosensa

Prosensa is a biopharmaceutical company focused on the discovery, development and commercialization of RNA modulating therapeutics. The company targets genetic disorders with a large unmet medical need, with a primary focus on neuromuscular disorders.

Prosensa was established to develop novel treatments for life-threatening diseases based on its RNA modulation platform. Prosensa intends to discover, develop and commercialize these products and to create a specialized orphan drug franchise.

Website www.prosensa.eu